James M. Inhofe bought CRSP

October 19, 2017 · STOCK Act disclosure

Senator James M. Inhofe (Republican-OK) bought CRISPR Therapeutics AG, a stock transaction, valued at $15,001 - $50,000. The trade took place on October 19, 2017 and was disclosed on November 8, 2017 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.

Type

Buy

Amount

$15,001 - $50,000

Transaction date

October 19, 2017

Disclosed

November 8, 2017

MemberJames M. Inhofe

ChamberSenate

Party / StateRepublican · OK

AssetCRISPR Therapeutics AG (CRSP)

Security typeStock

OwnerSelf

Amount range$15,001 - $50,000

Transaction dateOctober 19, 2017

Filing dateNovember 8, 2017

AmendmentNo

Asset description

CRISPR Therapeutics AG

View the original STOCK Act disclosure